[1]马鹏,王建村,黄杰,等.胶质瘤组织TMEM168的表达与病人预后的关系[J].中国临床神经外科杂志,2022,27(07):570-573.[doi:10.13798/j.issn.1009-153X.2022.07.013]
 MA Peng,WANG Jian-cun,HUANG Jie,et al.Expression of TMEM168 in glioma tissues and its relationship with glioma patients' prognosis[J].,2022,27(07):570-573.[doi:10.13798/j.issn.1009-153X.2022.07.013]
点击复制

胶质瘤组织TMEM168的表达与病人预后的关系()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年07期
页码:
570-573
栏目:
论著
出版日期:
2022-07-31

文章信息/Info

Title:
Expression of TMEM168 in glioma tissues and its relationship with glioma patients' prognosis
文章编号:
1009-153X(2022)07-0570-04
作者:
马鹏王建村黄杰薛强
201800 上海,中国人民解放军海军军医大学第三附属医院神经外科(马鹏、王建村、黄杰、薛强)
Author(s):
MA Peng WANG Jian-cun HUANG Jie XUE Qiang
Department of Neurosurgery, The Third Affiliated Hospital of Naval Military Medical University, PLA, Shanghai 201800, China
关键词:
胶质瘤跨膜蛋白168TMEM168生存预后危险因素基因表达
Keywords:
Glioma Transmembrane protein 168 Survival prognosis Risk factor Gene expression
分类号:
R739.41;Q786
DOI:
10.13798/j.issn.1009-153X.2022.07.013
文献标志码:
A
摘要:
目的 探讨跨膜蛋白(TMEM)168在胶质瘤组织中的表达及其与病人预后的关系。方法 选取2014年6月至2016年9月手术切除的符合标准的脑胶质瘤140例和颅脑损伤内减压术中切取的非肿瘤脑组织50例为对照,免疫组化染色检测TMEM168的表达。胶质瘤病人随访截止2021年10月,记录总生存期(OS)及无进展生存期(PFS)。结果 胶质瘤组织TMEM168高表达率[70.71%(99/140)]明显高于对照组[22.00%(11/50);P<0.05]。高级别胶质瘤组织TMEM168高表达率[81.58%(62/76)]明显高于低级别胶质瘤组织[57.81%(37/64);P<0.05]。140例胶质瘤术后随访3~60个月,死亡46例,复发87例。多因素Cox回归分析显示,TMEM168高表达是胶质瘤病人OS和PFS不良的独立危险因素(P<0.05)。生存曲线分析显示,TMEM168高表达胶质瘤病人中位OS、PFS较低表达病人明显缩短(P<0.05)。结论 胶质瘤组织TMEM168呈高表达,与胶质瘤病人不良生存预后有关。
Abstract:
Objective To investigate the expression of transmembrane protein (TMEM) 168 in glioma tissues and its relationship with glioma patients' prognosis. Methods The expressions of TMEM168 were detected using immunohistochemical staining in glioma tissues obtained from 140 glioma patients who underwent surgery from June 2014 to September 2016 and in non-tumor cerebral tissues obtained from 50 patients with traumatic brain injury who underwent decompression. Glioma patients were followed up until October 2021, and overall survival (OS) and progression-free survival (PFS) were recorded. Results The high expression rate of TMEM168 in glioma tissues [70.71% (99/140)]was significantly higher than that in the control group [22.00% (11/50); P<0.05]. The high expression rate of TMEM168 in high-grade glioma tissues [81.58% (62/76)]was significantly higher than that in low-grade glioma tissues [57.81% (37/64); P<0.05]. The followed up (range, 3~60 months) showed death in 46 patients and recurrence in 87 patients. Multivariate Cox regression analysis showed that high expression of TMEM168 was an independent risk factor for poor OS and PFS in glioma patients (P<0.05). Survival curve analysis showed that the median OS and PFS of glioma patients with high expression of TMEM168 were significantly shorter than those of glioma patients with low expression of TMEM168 (P<0.05). Conclusions The expression of TMEM168 in glioma tissues is up-regulated, which is related to the poor survival prognosis of glioma patients.

参考文献/References:

[1]Hicks WH, Bird CE, Pernik MN, et al. Large animal models of glioma: current status and future prospects [J]. Anticancer Res, 2021, 41(11): 5343-5353.
[2]Zhang N, Pan H, Liang X, et al. The roles of transmembrane family proteins in the regulation of store-operated Ca(2+) entry [J]. Cell Mol Life Sci, 2022, 79(2): 118.
[3]Zhang X, He Y, Jiang Y, et al. TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway [J]. Oncol Rep, 2021, 46(2): 176.
[4]Xu J, Su Z, Ding Q, et al. Inhibition of proliferation by knockdown of transmembrane (TMEM) 168 in glioblastoma cells via suppression of Wnt/β-Catenin pathway [J]. Oncol Res, 2019, 27(7): 819-826.
[5]田 伟,李 峰,张 彬. STRAP在人脑胶质瘤组织中的表达及临床意义[J]. 中国临床神经外科杂志,2020,25(8):510-513.
[6]徐梓珺,陈 郑,崔 萧,等. Polo样激酶1、真核翻译起始因子5A2在人脑胶质瘤组织的表达及其临床意义[J]. 中华实验外科杂志,2022,39(1):130-132.
[7]Beasley HK, Rodman TA, Collins GV, et al. TMEM135 is a novel regulator of mitochondrial dynamics and physiology with implications for human health conditions [J]. Cells, 2021, 10(7): 1750.
[8]Li C, Ou R, Chen Y, et al. Mutation analysis of TMEM family members for early-onset Parkinson's disease in Chinese population [J]. Neurobiol Aging, 2021, 101: 299.e291-299.e296.
[9]Segelcke D, Fischer HK, Hütte M, et al. Tmem160 contributes to the establishment of discrete nerve injury-induced pain behaviors in male mice [J]. Cell Rep, 2021, 37(12): 110152.
[10]Sharma VP, Tang B, Wang Y, et al. Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination [J]. Nat Commun, 2021, 12(1): 7300.
[11]Jiang XY, Wang L, Liu ZY, et al. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway [J]. J Recept Signal Trans-duct Res, 2021, 41(4): 371-377.
[12]Zhang S, Dai H, Li W, et al. TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway [J]. Cell Death Dis, 2021, 12(12): 1086.
[13]Fu K, Miyamoto Y, Sumi K, et al. Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit [J]. PLoS One, 2017, 12(12): e0189006.
[14]Shimizu A, Zankov DP, Sato A, et al. Identification of transmembrane protein 168 mutation in familial Brugada syndrome [J]. FASEB J, 2020, 34(5): 6399-6417.
[15]胡 荣,赵 武,张亚森,等. lncRNA-FTX与脑胶质瘤病人预后的相关性分析[J]. 中国临床神经外科杂志,2021,26(9):679-681.

相似文献/References:

[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
 CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(07):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
 XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(07):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(07):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
 YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(07):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
 HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(07):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
 DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(07):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
 PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(07):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
 FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(07):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
(2022-03-25收稿,2022-05-13修回)
通讯作者:王建村,E-mail:kfz3618@163.com
更新日期/Last Update: 2022-08-31